Cargando…
Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?
BACKGROUND: Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality of COVI...
Autores principales: | Aydemir, Selim, Aksakal, Emrah, Aydınyılmaz, Faruk, Gülcü, Oktay, Saraç, İbrahim, Aydın, Sidar Şiyar, Doğan, Remziye, Lazoğlu, Merve, Kalkan, Kamuran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261123/ https://www.ncbi.nlm.nih.gov/pubmed/35796916 http://dx.doi.org/10.1186/s43044-022-00291-9 |
Ejemplares similares
-
Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use
por: Aydınyılmaz, Faruk, et al.
Publicado: (2021) -
Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19
por: Gülcü, Oktay, et al.
Publicado: (2021) -
Cardiac Parameters Better Predict ICU Admission and Short-Term Mortality in Hospitalized Patients With COVID-19
por: Aksakal, Emrah, et al.
Publicado: (2023) -
Relationship Between Albumin-Corrected Anion Gap and Mortality in Hospitalized Heart Failure Patients
por: Aydın, Sidar Şiyar, et al.
Publicado: (2023) -
An investigation into hemodynamically significant coronary artery lesions predictors assessed by fractional flow reserve: A propensity score matching analysis
por: Aksu, Ugur, et al.
Publicado: (2019)